07.03.2008 08:51:00
|
Ambac Prices Common Stock and Equity Unit Offerings for an Aggregate of $1.5 Billion
Ambac Financial Group, Inc. (NYSE: ABK) (Ambac) today announced
that it has priced its $1.155 billion public offering of 171,111,111
shares of common stock, par value $0.01 per share, at $6.75 per share
and has granted the underwriters a 30-day option to purchase up to an
additional 25,666,667 shares of common stock to cover over-allotments,
if any.
In addition, Ambac announced that it has concurrently priced its $250
million public offering of 5 million equity units, with a stated amount
of $50 per unit. The equity units carry a total distribution rate of
9.5%. The threshold appreciation price of the equity units is $7.97
which represents a premium of approximately 18% over the concurrent
public offering price of Ambac’s common stock
of $6.75 per share. Ambac has granted the underwriters a 13-day option
to purchase up to an additional 750,000 equity units to cover
over-allotments, if any.
Ambac also placed 14,074,074 shares of common stock in a private
placement for $95 million with two financial institutions.
Michael Callen, Chairman and CEO of Ambac Financial Group, commented
that, "With this $1.5 billion capital raise
and our other capital strengthening actions and risk management
initiatives, we believe that our Ambac Assurance subsidiary will
maintain its triple-A financial strength ratings with Moody’s
and Standard & Poor’s. This is a most
important step in restoring the confidence of our customers in the
stability of our ratings and our inherent financial strength.”
Ambac currently intends to contribute the net proceeds from these
offerings to its insurance company subsidiary Ambac Assurance
Corporation in order to increase its capital position, less
approximately $100 million, which it intends to retain at Ambac to
provide incremental holding company liquidity to pay principal and
interest on its indebtedness, to pay its operating expenses and to pay
dividends on its capital stock. Proceeds from the settlement of the
purchase contracts forming a part of the equity units, in May 2011, will
be used to repay $142.5 million of the company's debt maturing August 1,
2011, to the extent that the cash proceeds of such settlement are
sufficient for such repayment. The remaining proceeds will be retained
at Ambac. Proceeds from the settlement of the purchase contracts will
not be used to repurchase common stock.
Credit Suisse Securities (USA) LLC, Citigroup Global Markets Inc., Banc
of America Securities LLC and UBS Investment Bank are acting as joint
book-running managers, and Keefe, Bruyette & Woods, Inc., Dresdner,
Kleinwort Securities LLC, BNY Capital Markets, Inc. and KeyBanc
Capital Markets Inc. are acting as co-managers, for the common stock
offering. Credit Suisse Securities (USA) LLC, Citigroup Global Markets
Inc., Banc of America Securities LLC and UBS Investment Bank are acting
as joint book-running managers, and Keefe, Bruyette & Woods, Inc. is
also acting as a co-manager, for the equity units offering. Sandler O’Neill
+ Partners, L.P. served as independent financial advisor to Ambac with
respect to these offerings.
The common stock and equity units will be sold pursuant to an effective
shelf registration statement previously filed with the Securities and
Exchange Commission (the "SEC"). Prospectus supplements relating to the
offerings of the common stock and equity units will be filed with the
SEC. Copies of the prospectus supplements and the accompanying base
prospectuses relating to these offerings may be obtained from Credit
Suisse Securities (USA) LLC, Eleven Madison Avenue, New York, NY 10004,
telephone: (800) 221-1037, facsimile: (212) 325-8057, or
Citigroup Global Markets Inc., Brooklyn Army Terminal, 140 58th Street,
8th Floor, Brooklyn, NY 11220, telephone: (718) 765-6732, facsimile:
(718) 765-6734, Banc of America Securities LLC, Capital Markets
Operations, 100 West 33rd Street, 3rd
Floor, New York, NY 10001, telephone: (800) 294-1322, email: dg.prospectus_distribution@bofasecurities.com,
or UBS Investment Bank, Attn: Prospectus Department, 299 Park Avenue,
New York, NY 10171, telephone: (888) 827-7275.
Ambac has filed a registration statement (including a prospectus and two
prospectus supplements) with the SEC for the offerings to which this
communication relates. Before you invest, you should read the prospectus
and prospectus supplement in that registration statement and other
documents Ambac has filed with the SEC for more complete information
about us and this offering. You may get these documents for free by
visiting EDGAR on the SEC Web site at www.sec.gov . Alternatively, Ambac, any underwriter or any dealer participating
in the offering will arrange to send you the prospectus and the
prospectus supplements if you request them.
Forward-Looking Statements
This release contains statements that may constitute "forward-looking
statements" within the meaning of the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Any or all of
management’s forward-looking statements here
or in other publications may turn out to be wrong and are based on Ambac’s
management current belief or opinions. Ambac’s
actual results may vary materially, and there are no guarantees about
the performance of Ambac’s securities. Among
events, risks, uncertainties or factors that could cause actual results
to differ materially are: (1) changes in the economic, credit, foreign
currency or interest rate environment in the United States and abroad;
(2) the level of activity within the national and worldwide credit
markets; (3) competitive conditions and pricing levels; (4) legislative
and regulatory developments; (5) changes in tax laws; (6) changes in our
business plan, including changes resulting from our decision to
discontinue writing new business in the financial services area, to
significantly reduce new underwriting of structured finance business and
to discontinue all new underwritings of structured finance business for
six months; (7) the policies and actions of the United States and other
governments; (8) changes in capital requirements whether resulting from
downgrades in our insured portfolio or changes in rating agencies’
rating criteria or other reasons; (9) changes in Ambac’s
and/or Ambac Assurance’s credit or financial
strength ratings; (10) changes in accounting principles or practices
relating to the financial guarantee industry or that may impact Ambac’s
reported financial results; (11) inadequacy of reserves established for
losses and loss expenses; (12) default by one or more of Ambac Assurance’s portfolio
investments, insured issuers, counterparties or reinsurers; (13) credit
risk throughout our business, including large single exposures to
reinsurers; (14) market spreads and pricing on insured collateralized
debt obligations ("CDOs”)
and other derivative products insured or issued by Ambac; (15) credit
risk related to residential mortgage securities and CDOs; (16) the risk
that holders of debt securities or counterparties on credit default
swaps or other similar agreements seek to declare events of default or
seek judicial relief or bring claims alleging violation or breach of
covenants by Ambac or one of its subsidiaries; (17) the risk that our
underwriting and risk management policies and practices do not
anticipate certain risks and/or the magnitude of potential for loss as a
result of unforeseen risks; (18) the risk of volatility in income and
earnings, including volatility due to the application of fair value
accounting, or FAS 133, to the portion of our credit enhancement
business which is executed in credit derivative form; (19) operational
risks, including with respect to internal processes, risk models,
systems and employees; (20) the risk of decline in market position;
(21) the risk that market risks impact assets in our investment
portfolio; (22) the risk of credit and liquidity risk due to unscheduled
and unanticipated withdrawals on investment agreements; (23) changes in
prepayment speeds on insured asset-backed securities; (24) factors that
may influence the amount of installment premiums paid to Ambac; (25) the
risk that we may be required to raise additional capital, which could
have a dilutive effect on our outstanding equity capital and/or future
earnings; (26) our ability or inability to raise additional capital,
including the risks that regulatory or other approvals for any plan to
raise capital are not obtained, or that various conditions to such a
plan, either imposed by third parties or imposed by Ambac or its Board
of Directors, are not satisfied and thus potentially necessary capital
raising transactions do not occur, or the risk that for other reasons
the Company cannot accomplish any potentially necessary capital raising
transactions, including the transactions contemplated hereby; (27) the
risk that Ambac’s holding company structure
and certain regulatory and other constraints, including adverse business
performance, affect Ambac’s ability to pay
dividends and make other payments; (28) the risk of litigation and
regulatory inquiries or investigations, and the risk of adverse outcomes
in connection therewith, which could have a material adverse effect on
our business, operations, financial position, profitability or cash
flows; (29) other factors discussed under "Risk
Factors” in this prospectus supplement,
described in the Risk Factors section in Part I, 1A of our Annual Report
on Form 10-K for the fiscal year ended December 31, 2007 and also
disclosed from time to time by Ambac in its subsequent reports on Form
10-Q and Form 8-K, which are or will be available on the Ambac website
at www.ambac.com
and at the SEC’s website, www.sec.gov;
and (30) other risks and uncertainties that have not been identified at
this time. Readers are cautioned that forward-looking statements speak
only as of the date they are made and that Ambac does not undertake to
update forward-looking statements to reflect circumstances or events
that arise after the date the statements are made. You are therefore
advised to consult any further disclosures we make on related subjects
in Ambac’s reports to the SEC.
Ambac Financial Group, Inc., headquartered in New York City, is a
holding company whose affiliates provide financial guarantees and
financial services to clients in both the public and private sectors
around the world. Ambac's principal operating subsidiary, Ambac
Assurance Corporation, a guarantor of public finance and structured
finance obligations, has earned triple-A ratings from Moody's Investors
Service, Inc. and Standard & Poor's Ratings Services; and a double-A
rating from Fitch, Inc. Moody's has placed Ambac's triple-A rating on
review for possible downgrade. Standard & Poor's has placed Ambac's
triple-A rating on "credit watch negative." Fitch has placed Ambac's
double-A rating on "rating watch negative." Ambac Financial Group, Inc.
common stock is listed on the New York Stock Exchange (ticker symbol
ABK).
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu AMBAC Financial Group Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |